51674-10-3Relevant articles and documents
BISCARBAMOYL DISELENIDES AS NEW CARBAMOYLATING REAGENTS. LEWIS ACID PROMOTED CARBAMOYLATION OF AROMATIC COMPOUNDS
Fujiwara, Shin-Ichi,Ogawa, Akiya,Kambe, Nobuaki,Ryu, Ilhyong,Sonoda, Noboru
, p. 6121 - 6124 (1988)
The reaction of biscarbamoyl diselenides with aromatic compounds in the presence of Lewis acids resulted in Friedel-Crafts type carbamoylation (Gatterman amide synthesis) to give corresponding aromatic amides in good yields.This methodology was successfully applied to aroylation and benzylation by use of dibenzoyl diselenide and dibenzyl diselenide, respectively.
Pd-Catalyst Containing a Hemilabile P,C-Hybrid Ligand in Amino Dicarbonylation of Aryl Halides for Synthesis of α-Ketoamides
Yang, Shu-Qing,Yao, Yin-Qing,Chen, Xiao-Chao,Lu, Yong,Zhao, Xiao-Li,Liu, Ye
, p. 1032 - 1041 (2021/05/07)
The amino dicarbonylation of aryl halides affording α-ketoamides with Pd catalysts is highly dependent on the stereoelectronic properties of the involved ligands. Ionic diphosphine ligand L4 can serve as precursor of a hemilabile P,C (phosphine, carbene)-hybrid ligand to form a stable Pd(II)-complex, Pd-L4. In contrast, analogues L1-L3 with a similar 1-(thiophen-3-yl)-benzimidazolyl skeleton behave as typical (mono/di)phosphines. The catalytic system resulting from the complexation of PdCl2(MeCN)2 and L4 exhibits good catalytic performance in terms of aryl iodides conversion (81-95%) and α-ketoamide selectivity (80-91%), as well as the available recyclability in the RTIL of [Bpy]BF4. The in situ FT-IR analysis reveals that the PdCl2(MeCN)2-L4 catalytic system favors the amino dicarbonylation toward α-ketoamides according to the proposed mechanism of cycle I, which involves two independent CO-insertion steps.
INHIBITORS OF SOX18 PROTEIN ACTIVITY FOR TREATING ANGIOGENESIS-AND/OR LYMPHANGIOGENESIS-RELATED DISEASES
-
Paragraph 0157; 0161, (2019/11/19)
Disclosed are compounds of a formula provided herein that show efficacy in the inhibition of SOX18 protein activity, and in particular with respect to the ability of SOX18 to bind DNA and/or particular protein partners. Further, methods of treating angiog
